José M Ferro Selected Research

Intracranial Sinus Thrombosis (Sinus Thrombosis)

1/2022	Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis.
1/2022	Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
11/2021	Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
11/2020	Dural Arteriovenous Fistulae After Cerebral Venous Thrombosis.
10/2018	Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis.
1/2014	Cerebral venous thrombosis causing posterior fossa lesions: description of a case series and assessment of safety of anticoagulation.
2/2013	Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial.
9/2010	Venous thromboembolic events after cerebral vein thrombosis.
4/2008	Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics.
1/2008	Are steroids useful to treat cerebral venous thrombosis?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José M Ferro Research Topics

Disease

24	Stroke (Strokes) 06/2021 - 04/2003
17	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 01/2008
15	Ischemic Stroke 09/2021 - 07/2008
11	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2022 - 01/2003
8	Seizures (Absence Seizure) 01/2021 - 03/2008
7	Thrombocytopenia (Thrombopenia) 10/2022 - 09/2021
5	Infections 06/2021 - 03/2008
5	Hemorrhage 04/2020 - 04/2003
5	Endocarditis 04/2020 - 01/2014
4	Atrial Fibrillation 06/2014 - 02/2003
3	Embolic Stroke 07/2021 - 10/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 01/2014
3	Transient Ischemic Attack 01/2021 - 04/2003
3	Hypertension (High Blood Pressure) 11/2017 - 03/2010
3	Cerebral Hemorrhage 01/2016 - 02/2007
2	Parkinson Disease (Parkinson's Disease) 08/2022 - 10/2020
2	COVID-19 11/2021 - 09/2021
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2021 - 02/2013
2	Neoplasms (Cancer) 09/2021 - 09/2014
2	Neurologic Manifestations (Neurological Manifestations) 01/2021 - 01/2021
2	Ataxia (Dyssynergia) 01/2021 - 10/2014
2	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 10/2014
2	Headache (Headaches) 01/2021 - 02/2007
2	Infarction (Infarctions) 01/2019 - 01/2006
2	Thrombosis (Thrombus) 02/2013 - 03/2008
1	Multiple Myeloma 09/2021
1	Hematologic Diseases (Blood Diseases) 09/2021
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 09/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 09/2021
1	Thrombotic Thrombocytopenic Purpura 09/2021
1	Leukemia 09/2021
1	Lymphoma (Lymphomas) 09/2021
1	Syncope (Fainting) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Deafness (Deaf Mutism) 01/2021
1	Atrophy 01/2021
1	Multiple Sclerosis 01/2021
1	Muscle Weakness 01/2021
1	Paralysis (Palsy) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Dementia (Dementias) 01/2021
1	Muscle Cramp (Cramp) 01/2021
1	Venous Thromboembolism 01/2021
1	Myotonia 01/2021
1	Cognitive Dysfunction 01/2021
1	Heart Neoplasms 01/2019
1	Aneurysm (Aneurysms) 01/2019
1	Fibrosis (Cirrhosis) 11/2018
1	Epilepsy (Aura) 12/2017
1	Hepatolenticular Degeneration (Wilson's Disease) 08/2016
1	Spontaneous Abortion (Miscarriage) 03/2016
1	Mental Disorders (Mental Disorder) 01/2016
1	Ischemia 01/2015

Drug/Important Bio-Agent (IBA)

10	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 02/2007
9	AnticoagulantsIBA 01/2022 - 01/2003
6	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2006
5	VaccinesIBA 10/2022 - 09/2021
5	Dabigatran FDA Link 01/2022 - 10/2018
4	ChAdOx1 nCoV-19IBA 01/2022 - 11/2021
4	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 10/2018
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 03/2008
4	Anticonvulsants (Antiepileptic Drugs)IBA 09/2017 - 03/2008
3	AntibodiesIBA 01/2022 - 01/2021
3	danaparoid (Orgaran)FDA Link 01/2020 - 03/2010
3	vinyltriethoxysilane (VTES)IBA 12/2019 - 09/2010
2	mRNA VaccinesIBA 01/2022 - 11/2021
2	COVID-19 VaccinesIBA 01/2022 - 01/2022
2	Ad26COVS1IBA 01/2022 - 01/2022
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2021 - 03/2010
2	Oral ContraceptivesIBA 06/2021 - 09/2014
2	SteroidsIBA 01/2021 - 01/2008
2	Metronidazole (Metric)FDA LinkGeneric 01/2021 - 01/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020 - 06/2014
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 04/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 04/2003
2	Vitamin K FDA Link 10/2018 - 03/2008
2	EnzymesIBA 01/2015 - 02/2012
1	BNT162 VaccineIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	thiamine triphosphorate (TTP)IBA 09/2021
1	Platelet Factor 4IBA 09/2021
1	Monoclonal AntibodiesIBA 09/2021
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	IntegrinsIBA 01/2021
1	RivaroxabanIBA 01/2019
1	GadoliniumIBA 11/2018
1	cyclo(Arg-Pro) (CI 4)IBA 12/2017
1	Contraceptive Agents (Contraceptives)IBA 09/2017
1	Biological ProductsIBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2015

Therapy/Procedure

11	Therapeutics 11/2021 - 01/2003
6	Thrombectomy 09/2021 - 04/2016
2	Secondary Prevention 06/2021 - 06/2021
2	Carotid Endarterectomy 11/2017 - 01/2017
2	Contraindications 03/2003 - 02/2003
1	Conservative Treatment 01/2019
1	Length of Stay 06/2018
1	Liver Transplantation 08/2016